SDAX Kursindex
|
7 549,29
|
54,10
|
0,72 %
|
Analysen zu SDAX Kursindex-Werten
| 11.12.25 | Jungheinrich Buy | Warburg Research | |
| 11.12.25 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
| 11.12.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 11.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 11.12.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 11.12.25 | SCHOTT Pharma Sector Perform | RBC Capital Markets | |
| 11.12.25 | Alzchem Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 10.12.25 | Mutares Buy | Warburg Research | |
| 10.12.25 | Carl Zeiss Meditec Neutral | UBS AG | |
| 10.12.25 | Dürr Neutral | UBS AG | |
| 09.12.25 | Carl Zeiss Meditec Overweight | Barclays Capital | |
| 09.12.25 | Klöckner Buy | Deutsche Bank AG | |
| 09.12.25 | Jungheinrich Kaufen | DZ BANK | |
| 09.12.25 | Ströer Buy | Deutsche Bank AG | |
| 09.12.25 | HelloFresh Hold | Deutsche Bank AG | |
| 09.12.25 | HORNBACH Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.12.25 | Carl Zeiss Meditec Overweight | Barclays Capital | |
| 08.12.25 | Klöckner Kaufen | DZ BANK | |
| 08.12.25 | HORNBACH Halten | DZ BANK | |
| 08.12.25 | HORNBACH Buy | Warburg Research | |
| 08.12.25 | Stabilus Buy | Warburg Research | |
| 08.12.25 | Klöckner Hold | Warburg Research | |
| 08.12.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 08.12.25 | Jungheinrich Overweight | Barclays Capital | |
| 08.12.25 | HORNBACH Add | Baader Bank | |
| 08.12.25 | SCHOTT Pharma Hold | Deutsche Bank AG | |
| 08.12.25 | Stabilus Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Dürr Outperform | Bernstein Research | |
| 08.12.25 | SCHOTT Pharma Equal Weight | Barclays Capital | |
| 05.12.25 | Jungheinrich Outperform | Bernstein Research | |
| 05.12.25 | Jungheinrich Buy | Jefferies & Company Inc. | |
| 05.12.25 | Dürr Buy | Warburg Research | |
| 05.12.25 | SCHOTT Pharma Kaufen | DZ BANK | |
| 05.12.25 | SCHOTT Pharma Buy | UBS AG | |
| 05.12.25 | SCHOTT Pharma Sector Perform | RBC Capital Markets | |
| 04.12.25 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
| 04.12.25 | SCHOTT Pharma Overweight | Barclays Capital | |
| 04.12.25 | Grand City Properties Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | TeamViewer Neutral | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| Jungheinrich | 6 |
| Dürr | 3 |
| ATOSS Software | 2 |
| FRIEDRICH VORWERK | 2 |
| CEWE Stiftung | 2 |
| Klöckner | 1 |
| PVA TePla | 1 |
| Vossloh | 1 |
| KSB | 1 |
| Douglas | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.